The US Food and Drug Administration (FDA) earlier this week released a new draft guidance detailing its approach to considering the benefits and risks for compliance and enforcement actions that could ...
The US Food and Drug Administration (FDA) issued a draft guidance on Wednesday that aims to shed light on how it assesses the benefits and risks of new drugs in deciding whether to approve them. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results